CEACAM6

From WikiMD's WELLNESSPEDIA

CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6) is a glycoprotein that is encoded by the CEACAM6 gene in humans. It is a member of the carcinoembryonic antigen (CEA) gene family.

Function[edit]

CEACAM6 is a cell surface receptor that plays a role in cell adhesion and in intracellular signaling. It is involved in various cellular processes such as apoptosis, cell proliferation, and differentiation. It is also implicated in cancer as it is overexpressed in certain types of cancer, including pancreatic cancer, colorectal cancer, and non-small cell lung cancer.

Structure[edit]

The CEACAM6 protein is a type II transmembrane glycoprotein. It consists of an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain contains three immunoglobulin-like domains, which are involved in cell adhesion.

Clinical significance[edit]

Overexpression of CEACAM6 has been associated with various types of cancer. It has been suggested as a potential biomarker for the detection and prognosis of certain cancers. In addition, it has been proposed as a target for cancer therapy.

See also[edit]

References[edit]



Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.